Latest filing published 29 Jun 2016 for Cartesian Therapeutics, Inc..
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Flagship Ventures Fund 2007, L.P.: trading record in brief
Flagship Ventures Fund 2007, L.P. discloses dealings in 4 companies, chiefly Receptos, Inc., Sesen Bio, Inc. and Cartesian Therapeutics, Inc. Over a trading history stretching from 14 May 2013 to 27 June 2016, the count stands at 20 filings.
The open-market side counts 4 purchases for €3.9M alongside 4 sales for €4.2M. On balance, insiders were net sellers of €303k. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
Half of the purchases are above €1.1M and half below.
On 29 June 2016 came the latest disclosure, a transaction in Cartesian Therapeutics, Inc. The clock since the last published purchase (13 February 2014) now reads 4,652 days. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Flagship Ventures Fund 2007, L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 318,752 sharesCommon StockSEC:0001104659-16-130141:0
- 631,458 sharesCommon StockSEC:0001104659-16-130141:1
- 235,042 sharesCommon StockSEC:0001104659-16-130141:2
- 241,718 sharesCommon StockSEC:0001104659-16-130141:3
- 193,777 sharesCommon StockSEC:0001104659-16-130141:4
- 1,930,369 shares0Common StockSEC:0001209191-14-043581:0
- 1,417,323 sharesCommon StockSEC:0001181431-14-006845:0
- 926,017 sharesCommon StockSEC:0001181431-14-006845:1
- 231,504 sharesCommon StockSEC:0001181431-14-006845:2
- 214,095 shares@ US$10.00Common StockSEC:0001181431-14-006845:3Canonical exit: 12 May 2014 (T+90)
- 131,722 shares@ US$10.00Common StockSEC:0001181431-14-006845:4Canonical exit: 12 May 2014 (T+90)
- 32,912 shares@ US$10.00Common StockSEC:0001181431-14-006845:5Canonical exit: 12 May 2014 (T+90)
- 155,583 shares@ US$25.03Common StockSEC:0001181431-13-059544:0
- 54,000 shares@ US$24.20Common StockSEC:0001181431-13-059544:1
- 904 shares@ US$25.10Common StockSEC:0001181431-13-059544:2
- 20,300 shares@ US$24.09Common StockSEC:0001181431-13-059544:3
- 3,860,738 shares0Common StockSEC:0001209191-13-038521:0
- 1,152,039 shares@ US$5.25Common StockSEC:0001104659-13-041517:0
- 550,873 shares@ US$7.73Common StockSEC:0001104659-13-041517:1
- 107,142 shares@ US$14.00Common StockSEC:0001104659-13-041517:2Canonical exit: 12 Aug 2013 (T+90)
20 of 20 declarations
